Evidence map›Paper›PMID 17872976›Full record

ArticleThe American journal of pathology2007

Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function.

Jitka A I Virag, Marsha L Rolle, Julia Reece, Sandrine Hardouin, Eric O Feigl, Charles E Murry

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 171 citations in OpenAlex.

  1. Trial
  2. Article
  3. Translational biology of human cardiac fibrosis.Nature cardiovascular research · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Angiogenesis: Biological Mechanisms and In Vitro Models.Annals of biomedical engineering · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. New Insights into the Reparative Angiogenesis after Myocardial Infarction.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jitka A I ViragDepartment of Pathology, University of Washington, Seattle, Washington, USA.
Marsha L Rolle
Julia Reece
Sandrine Hardouin
Eric O Feigl
Charles E Murry
University of Washington · USInstitute of Molecular Biology and Biophysics · RU

Funding

Vasular cell origins and fates in granulation tissueP01HL003174 · NHLBI · UNIVERSITY OF WASHINGTON · PI SCHWARTZ, EMILY J. · 1985 to 2007
$13.8M
Humna ES Cells for Cardiac Tissue EngineeringR24HL064387 · NHLBI · UNIVERSITY OF WASHINGTON · PI RATNER, BUDDY D · 2000 to 2004
$9.4M
Cell-Based Cardiac RepairR01HL084642 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E · 2007 to 2014
$4.9M
CARDIAC GRAFTS-SKELETAL MYOBLASTS - Stem Cell SupplementR01HL061553 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E · 1999 to 2005
$1.9M
NHLBI NIH HHS P01 HL003174NHLBI NIH HHS P01 HL03174NHLBI NIH HHS R01 HL061553NHLBI NIH HHS R01 HL084642NHLBI NIH HHS R01 HL61553NHLBI NIH HHS R24 HL064387NHLBI NIH HHS R24 HL64387
6 · The paper itself

Abstract

Fibroblast growth factor-2 (FGF2, bFGF) has been proposed to regulate wound healing and angiogenesis, but skin wound healing in FGF2-knockout (FGF2-KO) animals is only slightly delayed. To determine the role of FGF2 in myocardial infarct repair, we studied the evolution of left ventricular geometry, cell proliferation, matrix content, and cardiac function in mice lacking or overexpressing (FGF2-Tg) FGF2. Despite having no effect on initial infarct size, deletion of FGF2 resulted in reduced fibroblast proliferation and interstitial collagen deposition, decreased endothelial proliferation and vascular density, and decreased cardiomyocyte hypertrophy. Furthermore, FGF2-KO mice demonstrated a complete absence of scar contraction, resulting in increased final infarct size and marked increases in chamber size and infarct expansion. These deficits ultimately impaired left ventricular dP/dt compared with wild-type infarcted mice. Conversely, overexpression of FGF2 increased fibroblast proliferation and collagen deposition, accelerated endothelial proliferation, and enhanced cardiomyocyte hypertrophy after infarction. These changes curbed infarct expansion and preserved left ventricular function. Thus, FGF2 is an important regulator of cell proliferation, angiogenesis, collagen synthesis, myocyte hypertrophy, scar contraction, and, ultimately, left ventricular contractile function during infarct repair. FGF2 may be more important in healing of infarcts compared with skin wounds because of the mechanical stress under which infarcts heal.

Indexed as

Cell ProliferationAnimalsCell EnlargementEndothelial CellsFibroblast Growth Factor 2FibroblastsFibrosisHypertrophy, Left VentricularMaleMiceMice, Inbred C57BLMyocardial ContractionMyocardial InfarctionMyocardiumMyocytes, CardiacVentricular Function, LeftFibroblast Growth Factor 2

Identifiers

PMID17872976
PMCPMC2043505
OpenAlexW1545268534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.